Icd10cm Tabular Addenda 2025
Icd10cm Tabular Addenda 2025
Icd10cm Tabular Addenda 2025
2025 Addenda
No Change Chapter 1
No Change Certain infectious and parasitic diseases (A00-B99)
No Change Excludes1:
Revise from Waldenström macroglobulinemia (C88.0)
Revise to Waldenström macroglobulinemia (C88.00)
No Change C83.39 Diffuse large B-cell lymphoma, extranodal and solid organ sites
Add C83.398 Diffuse large B-cell lymphoma of other extranodal and solid organ sites
No Change Excludes1:
Revise from angioimmunoblastic T-cell lymphoma (C86.5)
Revise to angioimmunoblastic T-cell lymphoma (C86.50)
Revise from blastic NK-cell lymphoma (C86.4)
Revise to blastic NK-cell lymphoma (C86.40)
Revise from enteropathy-type T-cell lymphoma (C86.2)
Revise to enteropathy-type T-cell lymphoma (C86.20)
Revise from extranodal NK-cell lymphoma, nasal type (C86.0)
Revise to extranodal NK-cell lymphoma, nasal type (C86.00)
Revise from hepatosplenic T-cell lymphoma (C86.1)
Revise to hepatosplenic T-cell lymphoma (C86.10)
Revise from primary cutaneous CD30-positive T-cell proliferations (C86.6)
Revise to primary cutaneous CD30-positive T-cell proliferations (C86.60)
Revise from subcutaneous panniculitis-like T-cell lymphoma (C86.3)
Revise to subcutaneous panniculitis-like T-cell lymphoma (C86.30)
Add C86.00 Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
Add Extranodal NK/T-cell lymphoma, nasal type NOS
Add Extranodal NK/T-cell lymphoma, nasal type with failed remission
Add C86.20 Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
Add Enteropathy associated T-cell lymphoma NOS
Add Enteropathy associated T-cell lymphoma not having achieved remission
Add Enteropathy associated T-cell lymphoma with failed remission
Add Enteropathy-type (intestinal) T-cell lymphoma NOS
Add Enteropathy-type (intestinal) T-cell lymphoma with failed remission
Add C86.30 Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission
Add Subcutaneous panniculitis-like T-cell lymphoma NOS
Add Subcutaneous panniculitis-like T-cell lymphoma with failed remission
Add C86.60 Primary cutaneous CD30-positive T-cell proliferations not having achieved
remission
Add Lymphomatoid papulosis NOS
Add Lymphomatoid papulosis not having achieved remission
Add Lymphomatoid papulosis with failed remission
Add Primary cutaneous anaplastic large cell lymphoma NOS
Add Primary cutaneous anaplastic large cell lymphoma not having achieved remission
Add Primary cutaneous anaplastic large cell lymphoma with failed remission
Add Primary cutaneous CD30-positive large T-cell lymphoma NOS
Add Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
Add Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
Add Primary cutaneous CD30-positive T-cell proliferations NOS
Add Primary cutaneous CD30-positive T-cell proliferations with failed remission
No Change C88 Malignant immunoproliferative diseases and certain other B-cell lymphomas
Add C88.30 Immunoproliferative small intestinal disease not having achieved remission
Add Alpha heavy chain disease NOS
Add Alpha heavy chain disease not having achieved remission
Add Alpha heavy chain disease with failed remission
Add Immunoproliferative small intestinal disease NOS
Add Immunoproliferative small intestinal disease with failed remission
Add Mediterranean lymphoma NOS
Add Mediterranean lymphoma not having achieved remission
Add Mediterranean lymphoma with failed remission
No Change C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-
lymphoma]
Add C88.40 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
[MALT-lymphoma] not having achieved remission
Add Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-
lymphoma] NOS
Add Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-
lymphoma] with failed remission
Add Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] NOS
Add Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] not having
achieved remission
Add Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] with failed
remission
Add Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] NOS
Add Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] not having achieved
remission
Add Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] with failed remission
Add C88.41 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
[MALT-lymphoma], in remission
Add C88.80 Other malignant immunoproliferative diseases not having achieved remission
Add Other malignant immunoproliferative diseases NOS
Add Other malignant immunoproliferative diseases with failed remission
Add C88.90 Malignant immunoproliferative disease, unspecified not having achieved remission
Add Immunoproliferative disease NOS
Add Immunoproliferative disease NOS not having achieved remission
Add Immunoproliferative disease NOS with failed remission
Add Malignant immunoproliferative disease, unspecified NOS
Add Malignant immunoproliferative disease, unspecified with failed remission
No Change Aplastic and other anemias and other bone marrow failure syndromes (D60-D64)
No Change D61 Other aplastic anemias and other bone marrow failure syndromes
No Change D89 Other disorders involving the immune mechanism, not elsewhere classified
No Change D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
Add Use Additional code for adverse effect, if applicable, to identify immune checkpoint
inhibitors and immunostimulant drugs (T45.AX5)
No Change Chapter 4
No Change Endocrine, nutritional and metabolic diseases (E00-E89)
No Change E08.6 Diabetes mellitus due to underlying condition with other specified complications
No Change E09.6 Drug or chemical induced diabetes mellitus with other specified complications
No Change E13.6 Other specified diabetes mellitus with other specified complications
No Change Other disorders of glucose regulation and pancreatic internal secretion (E15-E16)
Delete Note: May be used as an additional code to identify functional activity associated with a carcinoid
tumor.
Delete Excludes1: diabetes with hyperosmolarity (E08, E09, E11, E13 with final characters .00 or .01)
Add Excludes2: diabetes with hyperosmolarity (E08, E09, E11, E13 with final characters .00 or .01)
No Change Excludes1:
Revise from Waldenström macroglobulinemia (C88.0)
Revise to Waldenström macroglobulinemia (C88.00)
Add Use Additional code to identify body mass index (BMI), if known (Z68.-)
No Change Chapter 5
No Change Mental, Behavioral and Neurodevelopmental disorders (F01-F99)
No Change Excludes2:
Add dementia with delirium or acute confusional state (F05)
Delete senile dementia with delirium or acute confusional state (F05)
No Change Excludes1:
Revise from unspecified dementia (F03)
Revise to unspecified dementia (F03.-)
No Change Excludes1:
Revise from dementia (F01.-, F02.-, F03)
Revise to dementia (F01.-, F02.-, F03.-)
No Change Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders (F20-F29)
No Change Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders (F40-F48)
No Change Behavioral syndromes associated with physiological disturbances and physical factors (F50-F59)
No Change F50 Eating disorders
No Change Excludes1:
Revise from bulimia nervosa (F50.2)
Revise to bulimia nervosa (F50.2-)
No Change Excludes1:
Revise from anorexia nervosa, binge eating/purging type (F50.02)
Revise to anorexia nervosa, binge eating/purging type (F50.02-)
No Change Behavioral and emotional disorders with onset usually occurring in childhood and adolescence (F90-
F98)
No Change F98 Other behavioral and emotional disorders with onset usually occurring in childhood and
adolescence
No Change Excludes1:
Delete dementia with Parkinsonism (G31.83)
Add neurocognitive disorder with Lewy bodies (G31.83)
No Change Excludes1:
Revise from senile dementia NOS (F03)
Revise to senile dementia NOS (F03.-)
No Change G31 Other degenerative diseases of nervous system, not elsewhere classified
No Change Excludes1:
Revise from dementia (F01.-, F02.-, F03)
Revise to dementia (F01.-, F02.-, F03.-)
Revise from H44.2A3 Degenerative myopia with choroidal neovascularization, bilateral eye
Revise to H44.2A3 Degenerative myopia with choroidal neovascularization, bilateral
Revise from H44.2B3 Degenerative myopia with macular hole, bilateral eye
Revise to H44.2B3 Degenerative myopia with macular hole, bilateral
Revise from H44.2C3 Degenerative myopia with retinal detachment, bilateral eye
Revise to H44.2C3 Degenerative myopia with retinal detachment, bilateral
Revise from H44.2E3 Degenerative myopia with other maculopathy, bilateral eye
Revise to H44.2E3 Degenerative myopia with other maculopathy, bilateral
No Change Chapter 9
No Change Diseases of the circulatory system (I00-I99)
Delete Excludes1: multiple valve disease specified a nonrheumatic (I34.-, I35.-, I36.-, I37.-, I38.-, Q22.-, Q23.-,
Q24.8-)
Add Excludes2: multiple valve disease specified as nonrheumatic (I34.-, I35.-, I36.-, I37.-, I38.-, Q22.-, Q23.-,
Q24.8-)
Add Use Additional code, if applicable, to identify specific organ dysfunction, such as:
Add acute kidney injury (N17.-)
Add acute myocardial infarction (I21.-)
Add acute pulmonary edema (left and/or right ventricular failure) (J81.0, I50.-)
Add aortic dissection (I71.0-)
Add cerebral hemorrhage (I60.-. I61.-, I62.-)
Add cerebral infarction (I63.-)
Add eclampsia (O15.-)
Add hypertensive encephalopathy (I67.4)
Add seizure (R56.9)
Add I26.03 Cement embolism of pulmonary artery with acute cor pulmonale
Add I26.04 Fat embolism of pulmonary artery with acute cor pulmonale
Revise from I26.93 Single subsegmental pulmonary embolism without acute cor pulmonale
Revise to I26.93 Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
Revise from I26.94 Multiple subsegmental pulmonary emboli without acute cor pulmonale
Revise to I26.94 Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
Add I26.95 Cement embolism of pulmonary artery without acute cor pulmonale
Add I26.96 Fat embolism of pulmonary artery without acute cor pulmonale
No Change Excludes1:
Revise from viral pericarditis due to Coxsakie virus (B33.23)
Revise to viral pericarditis due to Coxsackie virus (B33.23)
Delete Excludes1: aortic valve disorder of unspecified cause but with diseases of mitral and/or tricuspid valve(s)
(I08.-)
Delete aortic valve disorder specified as congenital (Q23.0, Q23.1)
Delete aortic valve disorder specified as rheumatic (I06.-)
Delete hypertrophic subaortic stenosis (I42.1)
Add Excludes2: aortic valve disorder of unspecified cause but with diseases of mitral and/or tricuspid valve(s)
(I08.-)
Add aortic valve disorder specified as congenital (Q23.0, Q23.1)
Add aortic valve disorder specified as rheumatic (I06.-)
Add hypertrophic subaortic stenosis (I42.1)
No Change Chapter 10
No Change Diseases of the respiratory system (J00-J99)
No Change J16 Pneumonia due to other infectious organisms, not elsewhere classified
No Change Excludes1:
Revise from chronic bronchiolitis (J44.-)
Revise to chronic bronchiolitis (J44.89)
No Change J34 Other and unspecified disorders of nose and nasal sinuses
No Change Suppurative and necrotic conditions of the lower respiratory tract (J85-J86)
Add Code also, if applicable, disruption of internal operation (surgical) wound (T81.32-)
No Change Chapter 11
No Change Diseases of the digestive system (K00-K95)
No Change Excludes2:
Revise from leukedema of tongue (K13.29)
Revise to leukoedema of tongue (K13.29)
Add Code also, if applicable, disruption of internal operation (surgical) wound (T81.32-)
Add Code also, if applicable, disruption of internal operation (surgical) wound (T81.32-)
Add Code also, if applicable, disruption of internal operation (surgical) wound (T81.32-)
No Change Chapter 12
No Change Diseases of the skin and subcutaneous tissue (L00-L99)
Add Use Additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or
sixth character 5)
No Change Excludes1:
Revise from lichen planopilaris (L66.1)
Revise to lichen planopilaris (L66.1-)
No Change M51.3 Other thoracic, thoracolumbar and lumbosacral intervertebral disc degeneration
Add M51.360 Other intervertebral disc degeneration, lumbar region with discogenic
back pain only
Add Other intervertebral disc degeneration, lumbar region with axial back pain only
Add M51.361 Other intervertebral disc degeneration, lumbar region with lower extremity
pain only
Add Other intervertebral disc degeneration, lumbar region with leg pain only
Add Other intervertebral disc degeneration, lumbar region with referred sclerotomal
pain only
Add M51.362 Other intervertebral disc degeneration, lumbar region with discogenic
back pain and lower extremity pain
Add Other intervertebral disc degeneration, lumbar region with discogenic back pain
and leg pain
Add Other intervertebral disc degeneration, lumbar region with axial back pain and
referred sclerotomal pain
Add M51.369 Other intervertebral disc degeneration, lumbar region without mention of
lumbar back pain or lower extremity pain
Add Other intervertebral disc degeneration, lumbar region without mention of lumbar
back pain or leg pain
Add Other intervertebral disc degeneration, lumbar region, NOS
Add M51.371 Other intervertebral disc degeneration, lumbosacral region with lower
extremity pain only
Add Other intervertebral disc degeneration, lumbosacral region with leg pain only
Add Other intervertebral disc degeneration, lumbosacral region with referred
sclerotomal pain only
Add Excludes1: intervertebral disc degeneration, lumbar region with lower extremity pain only
(M51.361)
Add intervertebral disc degeneration, lumbosacral region with lower extremity pain only
(M51.371)
Add Excludes1: intervertebral disc degeneration, lumbar region with discogenic back pain and lower
extremity pain (M51.362)
Add intervertebral disc degeneration, lumbosacral region with discogenic back pain and
lower extremity pain (M51.372)
Add Excludes1: intervertebral disc degeneration, lumbar region with discogenic back pain only
(M51.360)
Add intervertebral disc degeneration, lumbosacral region with discogenic back pain only
(M51.370)
Add M65.971 Unspecified synovitis and tenosynovitis, right ankle and foot
Add M65.972 Unspecified synovitis and tenosynovitis, left ankle and foot
Add M65.979 Unspecified synovitis and tenosynovitis, unspecified ankle and foot
No Change O24.1 Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium
No Change O24.3 Unspecified pre-existing diabetes mellitus in pregnancy, childbirth and the puerperium
No Change O24.8 Other pre-existing diabetes mellitus in pregnancy, childbirth, and the puerperium
No Change O24.9 Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium
Add Code also any other associated congenital malformations such as cardiac defects
Add Code also, if applicable, acquired aortic valve disorders, such as:
Add aortic (valve) insufficiency (nonrheumatic) (I35.1)
Add aortic (valve) stenosis (nonrheumatic) (I35.0)
Add aortic (valve) stenosis with insufficiency (nonrheumatic) (I35.2)
No Change Q87 Other specified congenital malformation syndromes affecting multiple systems
No Change Q87.8 Other specified congenital malformation syndromes, not elsewhere classified
No Change Symptoms and signs involving the digestive system and abdomen (R10-R19)
No Change Excludes1:
Revise from vomiting associated with bulimia nervosa (F50.2)
Revise to vomiting associated with bulimia nervosa (F50.2-)
No Change Excludes2:
Revise from bulimia nervosa (F50.2)
Revise to bulimia nervosa (F50.20)
No Change Symptoms and signs involving cognition, perception, emotional state and behavior (R40-R46)
No Change R41 Other symptoms and signs involving cognitive functions and awareness
No Change R41.8 Other symptoms and signs involving cognitive functions and awareness
No Change R41.89 Other symptoms and signs involving cognitive functions and awareness
Delete Anosognosia
No Change Excludes1:
Revise from senile psychosis (F03)
Revise to senile psychosis (F03.-)
No Change R63 Symptoms and signs concerning food and fluid intake
No Change Excludes1:
Revise from bulimia NOS (F50.2)
Revise to bulimia NOS (F50.2-)
No Change Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances
(T36-T50)
No Change T45 Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents,
not elsewhere classified
No Change T45.1 Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive
drugs
Add Excludes1: poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and
immunostimulant drugs (T45.A)
Add T45.A Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and
immunostimulant drugs
Add Excludes1: poisoning by, adverse effect of and underdosing of antineoplastic and
immunosuppressive drug (T45.1)
Add T45.AX Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors
and immunostimulant drugs
No Change T63 Toxic effect of contact with venomous animals and plants
No Change T65.3 Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues
Revise from Toxic effect of anilin [benzenamine]
Revise to Toxic effect of aniline [benzenamine]
No Change Complications of surgical and medical care, not elsewhere classified (T80-T88)
No Change T80.8 Other complications following infusion, transfusion and therapeutic injection
Add Excludes2: adverse effect of immune checkpoint inhibitors and immunostimulant drugs
(T45.AX5)
No Change T81.32 Disruption of internal operation (surgical) wound, not elsewhere classified
Delete Deep disruption or dehiscence of operation wound NOS
Delete Disruption or dehiscence of closure of internal organ or other internal tissue
Delete Disruption or dehiscence of closure of muscle or muscle flap
Delete Disruption or dehiscence of closure of ribs or rib cage
Delete Disruption or dehiscence of closure of skull or craniotomy
Delete Disruption or dehiscence of closure of sternum or sternotomy
Delete Disruption or dehiscence of closure of tendon or ligament
Delete Disruption or dehiscence of closure of superficial or muscular fascia
Add Code also, if applicable, disruption of internal operation (surgical) wound (T81.32-)
Add Code also, if applicable, disruption of internal operation (surgical) wound (T81.32-)
Add Use Additional code to identify body mass index (BMI), if known (Z68.-)
Add Note: Use one code, as available, for each receptor: Z17.0, Z17.1, Z17.2-, Z17.3-
Add Note: Assign a code from subcategory Z17.4- when only a combined receptor status is
documented
Add Z17.41 Hormone receptor positive
Add HR+
Add Z17.410 Hormone receptor positive with human epidermal growth factor receptor 2
positive status
Add HR+ with HER2+
Add Z17.411 Hormone receptor positive with human epidermal growth factor receptor 2
negative status
Add HR+ with HER2-
Add Z17.420 Hormone receptor negative with human epidermal growth factor receptor 2
positive status
Add HR- with HER2+
Add Z17.421 Hormone receptor negative with human epidermal growth factor receptor 2
negative status
Add HR- with HER2-
Add TNBC
Add Triple negative breast cancer
No Change Z45.3 Encounter for adjustment and management of implanted devices of the special senses
No Change Z45.32 Encounter for adjustment and management of implanted hearing device
No Change Excludes1:
Revise from Encounter for fitting and adjustment of hearing aide (Z46.1)
Revise to Encounter for fitting and adjustment of hearing aid (Z46.1)
No Change Persons with potential health hazards related to socioeconomic and psychosocial circumstances
(Z55-Z65)
Revise from Z68.54 Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age
Revise to Z68.54 Body mass index [BMI] pediatric, 95th percentile for age to less than 120% of the
95th percentile for age
Add Z68.55 Body mass index [BMI] pediatric, 120% of the 95th percentile for age to less than
140% of the 95th percentile for age
Add Z68.56 Body mass index [BMI] pediatric, greater than or equal to 140% of the 95th percentile
for age
No Change Persons with potential health hazards related to family and personal history and certain conditions
influencing health status (Z77-Z99)
No Change Z86.0 Personal history of in-situ and benign neoplasms and neoplasms of uncertain behavior
Delete Excludes1: adverse effect of prescribed drug taken as directed- code to adverse effect
Delete poisoning (overdose) -code to poisoning
Delete Excludes1: adverse effect of prescribed drug taken as directed- code to adverse effect
Delete poisoning (overdose) -code to poisoning